nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ERBB3—type 1 diabetes mellitus	0.507	0.629	CbGaD
Gefitinib—EGFR—type 1 diabetes mellitus	0.227	0.282	CbGaD
Gefitinib—ALB—type 1 diabetes mellitus	0.0724	0.0898	CbGaD
Gefitinib—ERBB3—peripheral nervous system—type 1 diabetes mellitus	0.00458	0.097	CbGeAlD
Gefitinib—ORM1—saliva—type 1 diabetes mellitus	0.00348	0.0737	CbGeAlD
Gefitinib—SBK1—retina—type 1 diabetes mellitus	0.00277	0.0588	CbGeAlD
Gefitinib—Bosutinib—PRKCQ—type 1 diabetes mellitus	0.00204	0.27	CrCbGaD
Gefitinib—CSNK1E—islet of Langerhans—type 1 diabetes mellitus	0.00179	0.038	CbGeAlD
Gefitinib—IRAK4—islet of Langerhans—type 1 diabetes mellitus	0.00176	0.0374	CbGeAlD
Gefitinib—MKNK2—islet of Langerhans—type 1 diabetes mellitus	0.00164	0.0348	CbGeAlD
Gefitinib—IRAK1—islet of Langerhans—type 1 diabetes mellitus	0.00164	0.0348	CbGeAlD
Gefitinib—CSNK1E—retina—type 1 diabetes mellitus	0.00153	0.0325	CbGeAlD
Gefitinib—MKNK2—retina—type 1 diabetes mellitus	0.00141	0.0298	CbGeAlD
Gefitinib—ERBB3—nephron tubule—type 1 diabetes mellitus	0.00139	0.0295	CbGeAlD
Gefitinib—MKNK1—retina—type 1 diabetes mellitus	0.00139	0.0294	CbGeAlD
Gefitinib—MKNK2—nephron tubule—type 1 diabetes mellitus	0.00132	0.028	CbGeAlD
Gefitinib—IRAK1—nephron tubule—type 1 diabetes mellitus	0.00132	0.028	CbGeAlD
Gefitinib—CSNK1E—pancreas—type 1 diabetes mellitus	0.00126	0.0267	CbGeAlD
Gefitinib—ERBB3—kidney—type 1 diabetes mellitus	0.00122	0.0259	CbGeAlD
Gefitinib—ERBB3—pancreas—type 1 diabetes mellitus	0.00122	0.0258	CbGeAlD
Gefitinib—Lapatinib—EGFR—type 1 diabetes mellitus	0.00121	0.161	CrCbGaD
Gefitinib—MKNK2—cardiovascular system—type 1 diabetes mellitus	0.00119	0.0252	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—type 1 diabetes mellitus	0.00117	0.0249	CbGeAlD
Gefitinib—MKNK2—pancreas—type 1 diabetes mellitus	0.00116	0.0245	CbGeAlD
Gefitinib—IRAK1—pancreas—type 1 diabetes mellitus	0.00116	0.0245	CbGeAlD
Gefitinib—IRAK4—lymphoid tissue—type 1 diabetes mellitus	0.00107	0.0227	CbGeAlD
Gefitinib—ERBB3—lymphoid tissue—type 1 diabetes mellitus	0.00105	0.0223	CbGeAlD
Gefitinib—MKNK2—lymphoid tissue—type 1 diabetes mellitus	0.000999	0.0212	CbGeAlD
Gefitinib—MKNK1—lymphoid tissue—type 1 diabetes mellitus	0.000986	0.0209	CbGeAlD
Gefitinib—STK10—cardiovascular system—type 1 diabetes mellitus	0.000967	0.0205	CbGeAlD
Gefitinib—STK10—kidney—type 1 diabetes mellitus	0.000946	0.02	CbGeAlD
Gefitinib—Vandetanib—ERBB3—type 1 diabetes mellitus	0.000893	0.118	CrCbGaD
Gefitinib—MAP2K5—cardiovascular system—type 1 diabetes mellitus	0.000863	0.0183	CbGeAlD
Gefitinib—Afatinib—EGFR—type 1 diabetes mellitus	0.000861	0.114	CrCbGaD
Gefitinib—Bosutinib—ERBB3—type 1 diabetes mellitus	0.000836	0.111	CrCbGaD
Gefitinib—STK10—lymphoid tissue—type 1 diabetes mellitus	0.000812	0.0172	CbGeAlD
Gefitinib—Erlotinib—EGFR—type 1 diabetes mellitus	0.000608	0.0805	CrCbGaD
Gefitinib—Proteinuria—Ramipril—type 1 diabetes mellitus	0.000568	0.053	CcSEcCtD
Gefitinib—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00056	0.0523	CcSEcCtD
Gefitinib—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.000539	0.0114	CbGeAlD
Gefitinib—Drug interaction—Ramipril—type 1 diabetes mellitus	0.000538	0.0502	CcSEcCtD
Gefitinib—ABCG2—nephron tubule—type 1 diabetes mellitus	0.000468	0.00991	CbGeAlD
Gefitinib—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.000434	0.0092	CbGeAlD
Gefitinib—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.000403	0.0376	CcSEcCtD
Gefitinib—Vandetanib—EGFR—type 1 diabetes mellitus	0.000401	0.053	CrCbGaD
Gefitinib—CYP1A1—kidney—type 1 diabetes mellitus	0.00039	0.00827	CbGeAlD
Gefitinib—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.000384	0.0358	CcSEcCtD
Gefitinib—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000384	0.00813	CbGeAlD
Gefitinib—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.000382	0.0357	CcSEcCtD
Gefitinib—CYP3A5—kidney—type 1 diabetes mellitus	0.000381	0.00808	CbGeAlD
Gefitinib—CYP3A5—pancreas—type 1 diabetes mellitus	0.000379	0.00803	CbGeAlD
Gefitinib—Bosutinib—EGFR—type 1 diabetes mellitus	0.000375	0.0496	CrCbGaD
Gefitinib—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.000326	0.0304	CcSEcCtD
Gefitinib—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.000307	0.0286	CcSEcCtD
Gefitinib—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000286	0.00607	CbGeAlD
Gefitinib—CYP3A4—kidney—type 1 diabetes mellitus	0.000286	0.00607	CbGeAlD
Gefitinib—CYP2D6—kidney—type 1 diabetes mellitus	0.000282	0.00597	CbGeAlD
Gefitinib—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000277	0.0258	CcSEcCtD
Gefitinib—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000272	0.0254	CcSEcCtD
Gefitinib—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.000271	0.0253	CcSEcCtD
Gefitinib—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000264	0.0246	CcSEcCtD
Gefitinib—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000263	0.0246	CcSEcCtD
Gefitinib—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000251	0.0234	CcSEcCtD
Gefitinib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000247	0.023	CcSEcCtD
Gefitinib—ABCB1—retina—type 1 diabetes mellitus	0.000245	0.00519	CbGeAlD
Gefitinib—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000237	0.0221	CcSEcCtD
Gefitinib—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000231	0.00489	CbGeAlD
Gefitinib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000226	0.0211	CcSEcCtD
Gefitinib—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000224	0.0209	CcSEcCtD
Gefitinib—Alopecia—Ramipril—type 1 diabetes mellitus	0.000222	0.0207	CcSEcCtD
Gefitinib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000218	0.0204	CcSEcCtD
Gefitinib—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000207	0.00439	CbGeAlD
Gefitinib—ABCB1—kidney—type 1 diabetes mellitus	0.000203	0.00429	CbGeAlD
Gefitinib—ABCB1—pancreas—type 1 diabetes mellitus	0.000201	0.00427	CbGeAlD
Gefitinib—Angioedema—Ramipril—type 1 diabetes mellitus	0.000199	0.0186	CcSEcCtD
Gefitinib—Malaise—Ramipril—type 1 diabetes mellitus	0.000197	0.0184	CcSEcCtD
Gefitinib—Erlotinib—ALB—type 1 diabetes mellitus	0.000194	0.0257	CrCbGaD
Gefitinib—Cough—Ramipril—type 1 diabetes mellitus	0.00019	0.0178	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000185	0.0172	CcSEcCtD
Gefitinib—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000182	0.0169	CcSEcCtD
Gefitinib—Shock—Ramipril—type 1 diabetes mellitus	0.000175	0.0163	CcSEcCtD
Gefitinib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000175	0.0163	CcSEcCtD
Gefitinib—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000174	0.0163	CcSEcCtD
Gefitinib—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000174	0.00369	CbGeAlD
Gefitinib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000173	0.0161	CcSEcCtD
Gefitinib—Anorexia—Ramipril—type 1 diabetes mellitus	0.00017	0.0158	CcSEcCtD
Gefitinib—Hypotension—Ramipril—type 1 diabetes mellitus	0.000166	0.0155	CcSEcCtD
Gefitinib—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000159	0.0148	CcSEcCtD
Gefitinib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000155	0.0144	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000154	0.0143	CcSEcCtD
Gefitinib—Fatigue—Ramipril—type 1 diabetes mellitus	0.000154	0.0143	CcSEcCtD
Gefitinib—Constipation—Ramipril—type 1 diabetes mellitus	0.000152	0.0142	CcSEcCtD
Gefitinib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000146	0.0136	CcSEcCtD
Gefitinib—Urticaria—Ramipril—type 1 diabetes mellitus	0.000142	0.0132	CcSEcCtD
Gefitinib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000141	0.0131	CcSEcCtD
Gefitinib—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000141	0.0131	CcSEcCtD
Gefitinib—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000131	0.0122	CcSEcCtD
Gefitinib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000128	0.0119	CcSEcCtD
Gefitinib—Vandetanib—ALB—type 1 diabetes mellitus	0.000128	0.0169	CrCbGaD
Gefitinib—Pruritus—Ramipril—type 1 diabetes mellitus	0.000126	0.0118	CcSEcCtD
Gefitinib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000122	0.0114	CcSEcCtD
Gefitinib—Vomiting—Ramipril—type 1 diabetes mellitus	0.000113	0.0106	CcSEcCtD
Gefitinib—Rash—Ramipril—type 1 diabetes mellitus	0.000112	0.0105	CcSEcCtD
Gefitinib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000112	0.0105	CcSEcCtD
Gefitinib—Nausea—Ramipril—type 1 diabetes mellitus	0.000106	0.00987	CcSEcCtD
Gefitinib—ERBB3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.34e-05	0.000104	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	1.33e-05	0.000104	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TYK2—type 1 diabetes mellitus	1.32e-05	0.000104	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.32e-05	0.000103	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.32e-05	0.000103	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.32e-05	0.000103	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.31e-05	0.000103	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.31e-05	0.000103	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—EGFR—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NOS3—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD4—type 1 diabetes mellitus	1.3e-05	0.000101	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD86—type 1 diabetes mellitus	1.3e-05	0.000101	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD40LG—type 1 diabetes mellitus	1.27e-05	9.95e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	1.27e-05	9.95e-05	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.26e-05	9.88e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—STAT3—type 1 diabetes mellitus	1.26e-05	9.86e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.26e-05	9.85e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.26e-05	9.84e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD8A—type 1 diabetes mellitus	1.26e-05	9.84e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.25e-05	9.81e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	1.25e-05	9.74e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.24e-05	9.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—type 1 diabetes mellitus	1.24e-05	9.7e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.22e-05	9.52e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—STAT3—type 1 diabetes mellitus	1.22e-05	9.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-B—type 1 diabetes mellitus	1.21e-05	9.46e-05	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—type 1 diabetes mellitus	1.2e-05	9.42e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—type 1 diabetes mellitus	1.2e-05	9.37e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	1.2e-05	9.37e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—type 1 diabetes mellitus	1.2e-05	9.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD86—type 1 diabetes mellitus	1.2e-05	9.37e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.19e-05	9.35e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TYK2—type 1 diabetes mellitus	1.19e-05	9.34e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL2—type 1 diabetes mellitus	1.19e-05	9.34e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—type 1 diabetes mellitus	1.19e-05	9.32e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.19e-05	9.31e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	1.19e-05	9.29e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—type 1 diabetes mellitus	1.18e-05	9.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ERBB3—type 1 diabetes mellitus	1.17e-05	9.15e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SST—type 1 diabetes mellitus	1.15e-05	9.03e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.15e-05	8.99e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	1.15e-05	8.98e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	1.15e-05	8.97e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—EGFR—type 1 diabetes mellitus	1.14e-05	8.96e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CD80—type 1 diabetes mellitus	1.14e-05	8.92e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2RA—type 1 diabetes mellitus	1.13e-05	8.87e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.13e-05	8.85e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	1.12e-05	8.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-A—type 1 diabetes mellitus	1.12e-05	8.77e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—type 1 diabetes mellitus	1.12e-05	8.75e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.11e-05	8.7e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—EGFR—type 1 diabetes mellitus	1.11e-05	8.65e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.1e-05	8.6e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.1e-05	8.57e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.1e-05	8.57e-05	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—type 1 diabetes mellitus	1.09e-05	8.55e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—STAT3—type 1 diabetes mellitus	1.09e-05	8.51e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—type 1 diabetes mellitus	1.08e-05	8.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—ERBB3—type 1 diabetes mellitus	1.08e-05	8.45e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—INS—type 1 diabetes mellitus	1.08e-05	8.43e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	1.07e-05	8.38e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—type 1 diabetes mellitus	1.07e-05	8.37e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	1.07e-05	8.34e-05	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—type 1 diabetes mellitus	1.06e-05	8.33e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ITPR3—type 1 diabetes mellitus	1.06e-05	8.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CCR5—type 1 diabetes mellitus	1.06e-05	8.31e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	1.06e-05	8.28e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	1.05e-05	8.23e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.04e-05	8.15e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—INS—type 1 diabetes mellitus	1.04e-05	8.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—HLA-A—type 1 diabetes mellitus	1.03e-05	8.1e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	1.03e-05	8.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	1.03e-05	8.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GCG—type 1 diabetes mellitus	1.03e-05	8.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.02e-05	8.01e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	1.02e-05	7.95e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.01e-05	7.94e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—type 1 diabetes mellitus	1.01e-05	7.92e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	1e-05	7.86e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—STAT3—type 1 diabetes mellitus	1e-05	7.86e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1e-05	7.86e-05	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—type 1 diabetes mellitus	1e-05	7.85e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—HBA1—type 1 diabetes mellitus	9.99e-06	7.82e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—type 1 diabetes mellitus	9.97e-06	7.8e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.96e-06	7.79e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—type 1 diabetes mellitus	9.94e-06	7.78e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOC3—type 1 diabetes mellitus	9.93e-06	7.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.9e-06	7.75e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GSTT1—type 1 diabetes mellitus	9.76e-06	7.63e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	9.72e-06	7.61e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	9.68e-06	7.57e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.62e-06	7.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.61e-06	7.52e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	9.61e-06	7.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.59e-06	7.5e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	9.5e-06	7.43e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	9.47e-06	7.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD80—type 1 diabetes mellitus	9.46e-06	7.4e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.44e-06	7.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—type 1 diabetes mellitus	9.41e-06	7.36e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	9.39e-06	7.34e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.27e-06	7.26e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—STAT3—type 1 diabetes mellitus	9.27e-06	7.26e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CD80—type 1 diabetes mellitus	9.15e-06	7.16e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—EGFR—type 1 diabetes mellitus	9.13e-06	7.14e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—HBA1—type 1 diabetes mellitus	9.11e-06	7.13e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.1e-06	7.12e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOC3—type 1 diabetes mellitus	9.05e-06	7.08e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	9.03e-06	7.07e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—type 1 diabetes mellitus	9e-06	7.04e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	8.99e-06	7.03e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	8.89e-06	6.96e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—type 1 diabetes mellitus	8.8e-06	6.88e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.74e-06	6.84e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD80—type 1 diabetes mellitus	8.73e-06	6.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.71e-06	6.81e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	8.69e-06	6.8e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—INS—type 1 diabetes mellitus	8.64e-06	6.76e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	8.61e-06	6.74e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.52e-06	6.67e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—type 1 diabetes mellitus	8.5e-06	6.65e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	8.48e-06	6.64e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—EGFR—type 1 diabetes mellitus	8.43e-06	6.59e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CD86—type 1 diabetes mellitus	8.38e-06	6.56e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—STAT3—type 1 diabetes mellitus	8.36e-06	6.54e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.36e-06	6.54e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—INS—type 1 diabetes mellitus	8.25e-06	6.46e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	8.23e-06	6.44e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	8.18e-06	6.4e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	8.13e-06	6.36e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.02e-06	6.27e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—type 1 diabetes mellitus	8.01e-06	6.26e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.99e-06	6.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TYK2—type 1 diabetes mellitus	7.99e-06	6.25e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	7.98e-06	6.25e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.98e-06	6.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.96e-06	6.22e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.93e-06	6.21e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	7.92e-06	6.2e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.83e-06	6.13e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.79e-06	6.1e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	7.77e-06	6.08e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.75e-06	6.06e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.73e-06	6.05e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.72e-06	6.04e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—type 1 diabetes mellitus	7.72e-06	6.04e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—type 1 diabetes mellitus	7.65e-06	5.99e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—EGFR—type 1 diabetes mellitus	7.6e-06	5.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—type 1 diabetes mellitus	7.59e-06	5.94e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.58e-06	5.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.56e-06	5.92e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	7.52e-06	5.89e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—type 1 diabetes mellitus	7.48e-06	5.85e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	7.48e-06	5.85e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	7.46e-06	5.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.44e-06	5.82e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	7.41e-06	5.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TYK2—type 1 diabetes mellitus	7.37e-06	5.77e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.36e-06	5.76e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	7.34e-06	5.74e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.33e-06	5.73e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—type 1 diabetes mellitus	7.3e-06	5.71e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	7.28e-06	5.7e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.27e-06	5.69e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS3—type 1 diabetes mellitus	7.24e-06	5.66e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—type 1 diabetes mellitus	7.22e-06	5.65e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GCG—type 1 diabetes mellitus	7.09e-06	5.54e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—type 1 diabetes mellitus	7.02e-06	5.49e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	6.96e-06	5.45e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.83e-06	5.34e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.74e-06	5.27e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.71e-06	5.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—type 1 diabetes mellitus	6.71e-06	5.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—type 1 diabetes mellitus	6.67e-06	5.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—type 1 diabetes mellitus	6.67e-06	5.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—type 1 diabetes mellitus	6.64e-06	5.2e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	6.58e-06	5.15e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.49e-06	5.08e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—type 1 diabetes mellitus	6.48e-06	5.07e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—INS—type 1 diabetes mellitus	6.45e-06	5.05e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.43e-06	5.03e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.42e-06	5.03e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	6.36e-06	4.98e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	6.21e-06	4.86e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	6.19e-06	4.84e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.12e-06	4.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CD80—type 1 diabetes mellitus	6.12e-06	4.79e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CAT—type 1 diabetes mellitus	6e-06	4.69e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—type 1 diabetes mellitus	5.95e-06	4.66e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	5.92e-06	4.63e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.9e-06	4.62e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.85e-06	4.58e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—type 1 diabetes mellitus	5.84e-06	4.57e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	5.8e-06	4.54e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—INS—type 1 diabetes mellitus	5.78e-06	4.52e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	5.66e-06	4.43e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—STAT3—type 1 diabetes mellitus	5.59e-06	4.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.59e-06	4.37e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.41e-06	4.23e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	5.38e-06	4.21e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.26e-06	4.11e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.23e-06	4.09e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.16e-06	4.04e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—STAT3—type 1 diabetes mellitus	5.16e-06	4.04e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.07e-06	3.97e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.95e-06	3.87e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.92e-06	3.85e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.91e-06	3.84e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	4.91e-06	3.84e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.89e-06	3.82e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.8e-06	3.76e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—type 1 diabetes mellitus	4.71e-06	3.68e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	4.62e-06	3.62e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—type 1 diabetes mellitus	4.54e-06	3.55e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	4.37e-06	3.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.3e-06	3.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—type 1 diabetes mellitus	4.3e-06	3.36e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.27e-06	3.34e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	4.24e-06	3.32e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	4.05e-06	3.17e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	4e-06	3.13e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—INS—type 1 diabetes mellitus	3.98e-06	3.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—type 1 diabetes mellitus	3.91e-06	3.06e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	3.83e-06	3e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.82e-06	2.99e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.78e-06	2.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.62e-06	2.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—type 1 diabetes mellitus	3.61e-06	2.82e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.57e-06	2.8e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NOS3—type 1 diabetes mellitus	3.49e-06	2.73e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.49e-06	2.73e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.29e-06	2.57e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	3.28e-06	2.56e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.26e-06	2.55e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.24e-06	2.53e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.2e-06	2.5e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.13e-06	2.45e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.06e-06	2.39e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.01e-06	2.36e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.99e-06	2.34e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.88e-06	2.26e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.86e-06	2.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—type 1 diabetes mellitus	2.53e-06	1.98e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.15e-06	1.68e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.97e-06	1.54e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.88e-06	1.47e-05	CbGpPWpGaD
